These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 15485398

  • 1. Proteinuria and hypertensive nephrosclerosis in African Americans.
    Toto RD.
    Kidney Int Suppl; 2004 Nov; (92):S102-4. PubMed ID: 15485398
    [Abstract] [Full Text] [Related]

  • 2. Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort.
    Toto RD, Greene T, Hebert LA, Hiremath L, Lea JP, Lewis JB, Pogue V, Sika M, Wang X, AASK Collaborative Research Group.
    Am J Kidney Dis; 2010 Nov; 56(5):896-906. PubMed ID: 20801567
    [Abstract] [Full Text] [Related]

  • 3. Hypertensive risk factors in kidney disease in African Americans.
    Fogo AB.
    Kidney Int Suppl; 2003 Feb; (83):S17-21. PubMed ID: 12864869
    [Abstract] [Full Text] [Related]

  • 4. Hypertension, glomerular hypertrophy and nephrosclerosis: the effect of race.
    Hughson MD, Puelles VG, Hoy WE, Douglas-Denton RN, Mott SA, Bertram JF.
    Nephrol Dial Transplant; 2014 Jul; 29(7):1399-409. PubMed ID: 24327566
    [Abstract] [Full Text] [Related]

  • 5. Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate.
    Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O'Connor D, Ojo A, Phillips R, Sika M, Wright J, African-American Study of Hypertension and Kidney Disease.
    Am J Kidney Dis; 2001 Oct; 38(4):744-53. PubMed ID: 11576877
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria.
    Obialo CI, Hewan-Lowe K.
    J Natl Med Assoc; 1998 Nov; 90(11):649-55. PubMed ID: 9828579
    [Abstract] [Full Text] [Related]

  • 9. ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trial.
    Douglas JG, Agodoa L.
    Kidney Int Suppl; 2003 Feb; (83):S74-6. PubMed ID: 12864879
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Net endogenous acid production is associated with a faster decline in GFR in African Americans.
    Scialla JJ, Appel LJ, Astor BC, Miller ER, Beddhu S, Woodward M, Parekh RS, Anderson CA, African American Study of Kidney Disease and Hypertension Study Group.
    Kidney Int; 2012 Jul; 82(1):106-12. PubMed ID: 22475819
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis.
    Alves TP, Wang X, Wright JT, Appel LJ, Greene T, Norris K, Lewis J, AASK Collaborative Research Group.
    J Am Soc Nephrol; 2010 Aug; 21(8):1361-9. PubMed ID: 20651163
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.